|
Zimmer Holdings Names Marc Casper to Board of Directors
WARSAW, Ind., Feb. 27 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc.
(NYSE: ZMH; SWX: ZMH) announced today that Marc N. Casper, Executive Vice
President and Chief Operating Officer of Thermo Fisher Scientific Inc., has
been appointed to its Board of Directors. Thermo Fisher Scientific, the
world leader in serving science, provides analytical instruments,
laboratory equipment, supplies and services used in life sciences,
healthcare, and environmental, industrial and safety markets. The company
had 2008 revenues of $10.5 billion and has 34,000 employees around the
world.
"We are delighted to welcome Marc Casper to the Zimmer board of
directors," said John L. McGoldrick, Chairman of the Board of Directors.
"Marc's record of achievement combines very successful experiences both in
operations and in strategy development and we are looking forward to his
contributions."
Prior to being named Chief Operating Officer, Mr. Casper served as
President of Thermo Fisher's Analytical Technologies businesses following
the merger of Thermo Electron and Fisher Scientific in 2006. He held
executive positions since joining Thermo Electron in 2001. Previously, Mr.
Casper served as President, Chief Executive Officer and a Director of
Kendro Laboratory Products, and as President, Americas, for Dade Behring,
Inc. Mr. Casper currently also serves on the board of The Advisory Board
Company, a healthcare best practices research and consulting organization.
Mr. Casper earned an MBA with high distinction from Harvard Business
School and is a graduate of Wesleyan University, where he received a
bachelor's degree in economics.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is a
worldwide leader in designing, developing, manufacturing and marketing
orthopaedic reconstructive, spinal and trauma devices, dental implants, and
related surgical products. Zimmer has operations in more than 25 countries
around the world and sells products in more than 100 countries. Zimmer's
2008 sales were approximately $4.1 billion. The Company is supported by the
efforts of more than 8,500 employees worldwide.
For more information about Zimmer, visit http://www.zimmer.com
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about
the orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are
not guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange
Commission. We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on
which the forward-looking statements are based are reasonable, there can be
no assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all forward-looking
statements contained in this document.
|
